Clinical and Epidemiological Characteristics of Scarlet Fever in Russia

E. Glushkova, A. Brazhnikov, S. V. Krasnova, L. Glazovskaya, A. Savkina, N. Nikitin, V. A. Korshunov, N. Briko
{"title":"Clinical and Epidemiological Characteristics of Scarlet Fever in Russia","authors":"E. Glushkova, A. Brazhnikov, S. V. Krasnova, L. Glazovskaya, A. Savkina, N. Nikitin, V. A. Korshunov, N. Briko","doi":"10.31631/2073-3046-2023-22-3-14-25","DOIUrl":null,"url":null,"abstract":"Relevance. In recent decades, large outbreaks of scarlet fever have been reported in European and Asian countries. Severe forms of the infection have become more frequent and the number of complications has also increased.Aim. To assess the incidence of scarlet fever in the Russian Federation using the official statistical sources, to identify the clinical features of scarlet fever among adults.Materials and methods. Analysis of the level and dynamics of the long-term incidence of scarlet fever in the entire population and among different age groups in Russia from 1890 to 2021 was performed based on the data of annual statistical forms. A clinical and epidemiological descriptive retrospective census study was conducted using data from the case histories of patients diagnosed with “scarlet fever” in The Infectious Disease Clinical Hospital No. 2 Moscow Healthcare Department from 2010 to 2022.Results. Three major cycles (40-50 years) can be distinguished in the long term with regard to incidence. In 1986, the rise in incidence was noted after 30 years since the previous one and it was less intensive. In the first cycle, rates increased gradually over almost 10 years beginning from 1891. In subsequent years, the incidence remained high (220-280 per 100,000), decreasing markedly to 50-60 per 100,000 population only by 1917-1918. The second cycle, from 1918 to 1942, was characterized by increasing rates (up to 462 per 100,000 population). In the third cycle (1946 - 1981), incidence rate reached a peak by 1955 (531.8 per 100,000 population), and started to gradually decrease afterwards. There were cycles lasting 3–6 years in in this period The fourth cycle (1982-1991) was not so large. In recent years (2007–2021), the incidence decreased 7.3 times (from 45.4 to 6.2 per 100 thousand). The average incidence rate during this period was 29.8 per 100 thousand. In 2022, the incidence of streptococcal infection increased 2.8 times (including scarlet fever – 3 times). The incidence increases were observed in the group 0-14 years and 14 and older (from 298,2 to 34,1 and from1,6 to 0,1respectively). As in the previous years (fourth cycle), children aged 3-6 years were the main contributors to the incidence of scarlet fever (the average incidence rate – 452,1 per 100,000). The average age of patients admitted to the hospital was 24 years (18–45 years). There was an increase in the average age of patients since 2017. During the study period, the number of hospitalized adults with scarlet fever decreased by half. In most cases (98.56%) the patients had a moderate condition at admission and only 3 had a severe condition (1.44%). The most common comorbid diagnoses were ENT-organs infections (9%), urinary tract infections (3.35%) and Wolf-Parkinson-White syndrome (2.87%). Scarlet fever had a complicated course of infection in 19 patients (9.09%). In the treatment were used cephalosporin (52.63%) and penicillin (41.63%).Conclusions. This study demonstrated a stable downward trend in the incidence of scarlet fever in the population of the Russian Federation in recent years until 2021. In 2022, the incidence increased 3 times (18.7 per 100 thousand). The number of hospitalizations among adults with scarlet fever and the number of patients with complications have decreased. The average age of patients by 5 years have increased. The treatment was carried out in accordance with clinical recommendations and the antibiotic resistance of the pathogen.","PeriodicalId":11736,"journal":{"name":"Epidemiology and Vaccinal Prevention","volume":"4 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Epidemiology and Vaccinal Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31631/2073-3046-2023-22-3-14-25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Relevance. In recent decades, large outbreaks of scarlet fever have been reported in European and Asian countries. Severe forms of the infection have become more frequent and the number of complications has also increased.Aim. To assess the incidence of scarlet fever in the Russian Federation using the official statistical sources, to identify the clinical features of scarlet fever among adults.Materials and methods. Analysis of the level and dynamics of the long-term incidence of scarlet fever in the entire population and among different age groups in Russia from 1890 to 2021 was performed based on the data of annual statistical forms. A clinical and epidemiological descriptive retrospective census study was conducted using data from the case histories of patients diagnosed with “scarlet fever” in The Infectious Disease Clinical Hospital No. 2 Moscow Healthcare Department from 2010 to 2022.Results. Three major cycles (40-50 years) can be distinguished in the long term with regard to incidence. In 1986, the rise in incidence was noted after 30 years since the previous one and it was less intensive. In the first cycle, rates increased gradually over almost 10 years beginning from 1891. In subsequent years, the incidence remained high (220-280 per 100,000), decreasing markedly to 50-60 per 100,000 population only by 1917-1918. The second cycle, from 1918 to 1942, was characterized by increasing rates (up to 462 per 100,000 population). In the third cycle (1946 - 1981), incidence rate reached a peak by 1955 (531.8 per 100,000 population), and started to gradually decrease afterwards. There were cycles lasting 3–6 years in in this period The fourth cycle (1982-1991) was not so large. In recent years (2007–2021), the incidence decreased 7.3 times (from 45.4 to 6.2 per 100 thousand). The average incidence rate during this period was 29.8 per 100 thousand. In 2022, the incidence of streptococcal infection increased 2.8 times (including scarlet fever – 3 times). The incidence increases were observed in the group 0-14 years and 14 and older (from 298,2 to 34,1 and from1,6 to 0,1respectively). As in the previous years (fourth cycle), children aged 3-6 years were the main contributors to the incidence of scarlet fever (the average incidence rate – 452,1 per 100,000). The average age of patients admitted to the hospital was 24 years (18–45 years). There was an increase in the average age of patients since 2017. During the study period, the number of hospitalized adults with scarlet fever decreased by half. In most cases (98.56%) the patients had a moderate condition at admission and only 3 had a severe condition (1.44%). The most common comorbid diagnoses were ENT-organs infections (9%), urinary tract infections (3.35%) and Wolf-Parkinson-White syndrome (2.87%). Scarlet fever had a complicated course of infection in 19 patients (9.09%). In the treatment were used cephalosporin (52.63%) and penicillin (41.63%).Conclusions. This study demonstrated a stable downward trend in the incidence of scarlet fever in the population of the Russian Federation in recent years until 2021. In 2022, the incidence increased 3 times (18.7 per 100 thousand). The number of hospitalizations among adults with scarlet fever and the number of patients with complications have decreased. The average age of patients by 5 years have increased. The treatment was carried out in accordance with clinical recommendations and the antibiotic resistance of the pathogen.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
俄罗斯猩红热的临床和流行病学特征
的相关性。近几十年来,据报道在欧洲和亚洲国家爆发了大规模的猩红热。严重的感染形式变得更加频繁,并发症的数量也在增加。利用官方统计资料评估俄罗斯联邦猩红热的发病率,确定成人猩红热的临床特征。材料和方法。根据年度统计表数据,分析俄罗斯1890 - 2021年全人群及不同年龄组猩红热长期发病率水平和动态。对2010 - 2022年莫斯科第二传染病临床医院诊断为“猩红热”的患者进行了临床和流行病学描述性回顾性普查研究。就发病率而言,从长期来看可以区分出三个主要周期(40-50年)。1986年的发病率上升是在上一次病例发生30年后出现的,而且发病率的上升程度有所降低。在第一个周期中,从1891年开始,利率在近10年的时间里逐渐上升。在随后的几年里,发病率仍然很高(每10万人中有220-280人),到1917-1918年才显著下降到每10万人中有50-60人。第二个周期,从1918年至1942年,其特点是发病率上升(每10万人中高达462人)。在第三个周期(1946 - 1981),发病率在1955年达到高峰(每10万人531.8例),之后开始逐渐下降。第四个周期(1982-1991)没有这么大。近年来(2007-2021年),发病率下降了7.3倍(从每10万人45.4降至6.2)。同期的平均发病率为每10万人29.8例。2022年,链球菌感染的发病率增加了2.8倍(包括猩红热- 3倍)。0-14岁组和14岁及以上组的发病率增加(分别从298,2到34,1和从1,6到0,1)。与前几年(第四个周期)一样,3-6岁儿童是猩红热发病的主要原因(平均发病率为每10万人45.2例)。入院患者的平均年龄为24岁(18-45岁)。自2017年以来,患者的平均年龄有所增加。在研究期间,因猩红热住院的成人人数减少了一半。绝大多数(98.56%)患者入院时病情为中度,仅有3例(1.44%)为重度。最常见的合并症诊断为鼻窦器官感染(9%)、尿路感染(3.35%)和Wolf-Parkinson-White综合征(2.87%)。19例(9.09%)患者感染过程复杂。治疗以头孢菌素(52.63%)和青霉素(41.63%)为主。这项研究表明,到2021年,近年来俄罗斯联邦人口中猩红热发病率呈稳定下降趋势。2022年,发病率增加了3倍(18.7 / 10万)。成人猩红热患者的住院人数和并发症患者的人数已经减少。患者的平均年龄增加了5岁。根据临床建议和病原菌的抗生素耐药性进行治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Serogroup B Protein Meningococcal Vaccines and the Formation of Immune Protection against Gonorrhea Obtaining and Characterization of Experimental Diagnostic Brucellosis Rabbit Sera for the Development of a National Standard for Brucellosis Serum New Russian Trivalent Hepatitis B Vaccine (Bubo®­-Unigep): Reactogenicity, Safety and Immunological Efficacy Bacterial Infections Transmitted by Ticks in Barnaul: Epidemiological and Epizootological Situation, Diagnostic Problems Factors Determining Adherence to Hand Antisepsis by Healthcare Workers during Pandemic Infection Spread (as exemplified by COVID­-19)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1